Analysen von Keyur Parekh
| 16.05.14 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.14 | GSK Neutral | Goldman Sachs Group Inc. | |
| 13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 13.05.14 | Roche buy | Goldman Sachs Group Inc. | |
| 16.04.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.04.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 08.04.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 13.06.12 | Roche buy | Goldman Sachs Group Inc. | |
| 13.06.12 | Sanofi sell | Goldman Sachs Group Inc. | |
| 30.11.10 | Roche buy | Goldman Sachs Group Inc. | |
| 22.11.10 | Roche buy | Goldman Sachs Group Inc. | |
| 19.11.10 | Roche buy | Goldman Sachs Group Inc. | |
| 11.10.10 | Roche buy | Goldman Sachs Group Inc. | |
| 01.07.10 | AstraZeneca halten | Goldman Sachs Group Inc. | |